Alzheimer's disease drug development pipeline: 2017

Cited by (556)

Items 101–200 of 556

1. Associations of AT(N) biomarkers with neuropsychiatric symptoms in preclinical Alzheimer’s disease and cognitively unimpaired individuals
   Kok Pin Ng, Hui Jin Chiew, Pedro Rosa‐Neto, Nagaendran Kandiah, Zahinoor Ismail, Serge G. Gauthier · 2021 · Translational Neurodegeneration
2. Effects of sustainability on WoM intention and revisit intention, with environmental awareness as a moderator
   Andriani Kusumawati, Humam Santosa Utomo, Suharyono Suharyono, Sunarti Sunarti · 2019 · Management of Environmental Quality An International Journal
3. The 1,3,5-Triazine Derivatives as Innovative Chemical Family of 5-HT6 Serotonin Receptor Agents with Therapeutic Perspectives for Cognitive Impairment
   Gniewomir Latacz, Annamaria Lubelska, Magdalena Jastrzębska‐Więsek, Anna Partyka, Małgorzata Anna Marć, Grzegorz Satała, Daria Wilczyńska, Magdalena Kotańska, Małgorzata Więcek, Katarzyna H. Kaminska et al. · 2019 · International Journal of Molecular Sciences
4. Impact of COVID-19 on Alzheimer’s Disease Risk: Viewpoint for Research Action
   Abate, Giulia, Memo, Maurizio, Uberti, Daniela · 2020 · Healthcare
5. AdipoRon induces AMPK activation and ameliorates Alzheimer's like pathologies and associated cognitive impairment in APP/PS1 mice
   Mayuri Khandelwal, Kapil Manglani, Prabhat Upadhyay, Mohammad Azad, Sarika Gupta · 2022 · Neurobiology of Disease
6. MMP13 inhibition rescues cognitive decline in Alzheimer transgenic mice via BACE1 regulation
   Binglin Zhu, Yan Long, Wei Luo, Zhen Yan, Yujie Lai, Lige Zhao, Weihui Zhou, Yan‐Jiang Wang, Lin‐Lin Shen, Lu Liu et al. · 2018 · Brain
7. Cryo-EM of Aβ fibrils from mouse models find tg-APPArcSwe fibrils resemble those found in patients with sporadic Alzheimer’s disease
   Mara Zielinski, Fernanda S. Peralta Reyes, Lothar Gremer, Sarah Schemmert, Benedikt Frieg, Luisa U. Schäfer, Antje Willuweit, Lili Donner, Margitta Elvers, Lars N. G. Nilsson et al. · 2023 · Nature Neuroscience
8. Network pharmacology-based strategy to investigate pharmacological mechanisms of Tinospora sinensis for treatment of Alzheimer's disease
   Feng Zhou, Kunlun He, Guan Yang, Xiyang Yang, Yaohui Chen, Meng-Sheng Sun, Xiaopeng Qiu, Feixia Yan, Huilian Huang, Lihua Yao et al. · 2020 · Journal of Ethnopharmacology
9. A Review of the Recent Advances in Alzheimer’s Disease Research and the Utilization of Network Biology Approaches for Prioritizing Diagnostics and Therapeutics
   Rima Hajjo, Dima A. Sabbah, Osama H. Abusara, Abdel Qader Al Bawab · 2022 · Diagnostics
10. Alzheimer Disease: Perspectives from Epidemiology and Genetics
    Jonathan L. Haines · 2018 · The Journal of Law Medicine & Ethics
11. Characteristics and advantages of adeno-associated virus vector-mediated gene therapy for neurodegenerative diseases
    Yuan Qu, Yi Liu, Ahmed Fayyaz Noor, Johnathan Tran, Rui Li · 2019 · Neural Regeneration Research
12. Targeting both BDNF/TrkB pathway and delta-secretase for treating Alzheimer's disease
    Jianming Liao, Chun Chen, Eun Hee Ahn, Xia Liu, Hua Li, Laura E. Edgington‐Mitchell, Zhonghua Lu, Shuping Ming, Keqiang Ye · 2021 · Neuropharmacology
13. Genetic and multi‐omic risk assessment of Alzheimer's disease implicates core associated biological domains
    Cary, Gregory A., Wiley, Jesse C., Gockley, Jake, Keegan, Stephen, Amirtha Ganesh, Sai Sruthi, Heath, Laura, Butler, Robert R., Mangravite, Lara M., Logsdon, Benjamin A., Longo, Frank M. et al. · 2024 · Alzheimer's & Dementia: Translational Research & Clinical Interventions
14. The evolving landscape of Alzheimer’s disease therapy: From Aβ to tau
    Jean‐Philippe Courade, Henrik Zetterberg, Günter U. Höglinger, Ilse Dewachter · 2025 · Cell
15. Clinical Pharmacokinetics and Pharmacodynamics of Drugs in the Central Nervous System
    Nithya Srinivas, Kaitlyn Maffuid, Angela D. M. Kashuba · 2018 · Clinical Pharmacokinetics
16. Tacripyrimidines, the first tacrine-dihydropyrimidine hybrids, as multi-target-directed ligands for Alzheimer's disease
    Mourad Chioua, Eleonora Buzzi, Ignacio Moraleda, Isabel Iriepa, Maciej Maj, Artur Wnorowski, Catia Giovannini, Anna Tramarin, Federica Portali, Lhassane Ismaïli et al. · 2018 · European Journal of Medicinal Chemistry
17. Key Peptides and Proteins in Alzheimer’s Disease
    Botond Penke, Ferenc Bogár, Gábor Paragi, János Gera, Lívia Fülöp · 2019 · Current Protein and Peptide Science
18. Stem Cell Therapy for Alzheimer's Disease.
    F. Han, Jian-Zhong Bi, Li-Yan Qiao, O. Arancio · 2020 · Advances in Experimental Medicine and Biology
19. Pre‐diagnostic cognitive and functional impairment in multiple sporadic neurodegenerative diseases
    Swaddiwudhipong, Nol, Whiteside, David J., Hezemans, Frank H., Street, Duncan, Rowe, James B., Rittman, Timothy · 2023 · Alzheimer's & Dementia
20. Disease-modifying benefit of Fyn blockade persists after washout in mouse Alzheimer's model
    Levi M. Smith, Rong Zhu, Stephen M. Strittmatter · 2017 · Neuropharmacology
21. Advances in amyloid beta oligomer detection applications in Alzheimer's disease
    Angelo Jamerlan, Seong Soo A. An, John Hulme · 2020 · TrAC Trends in Analytical Chemistry
22. Passive Aβ Immunotherapy: Current Achievements and Future Perspectives
    Stephan Schilling, Jens‐Ulrich Rahfeld, Inge Lues, Cynthia Ann Lemere · 2018 · Molecules
23. Clinical drug development for dementia with Lewy bodies: past and present
    Garam Lee, Jeffrey L. Cummings, Boris Decourt, James B. Leverenz, Marwan Noel Sabbagh · 2019 · Expert Opinion on Investigational Drugs
24. Altered Neurochemistry in Alzheimer’s Disease: Targeting Neurotransmitter Receptor Mechanisms and Therapeutic Strategy
    Sunpreet Kaur, G. DasGupta, Shamsher Singh · 2019 · Neurophysiology
25. Design, synthesis and evaluation of novel dimethylamino chalcone-O-alkylamines derivatives as potential multifunctional agents against Alzheimer’s disease
    Zhipei Sang, Qing Song, Zhongcheng Cao, Yong Deng, Zhenghuai Tan, Li Zhang · 2021 · European Journal of Medicinal Chemistry
26. Role of Mitochondrial Dysfunctions in Neurodegenerative Disorders: Advances in Mitochondrial Biology
    Divya Sri Kathiresan, Rubadevi Balasubramani, Kamalesh Marudhachalam, Piyush Jaiswal, Nivedha Ramesh, Gunna Sureshbabu Suruthi, Puthamohan Vinayaga Moorthi, Murali Vijayan · 2024 · Molecular Neurobiology
27. Recent developments with tau-based drug discovery
    Khalid Iqbal, Fei Liu, Cheng‐Xin Gong · 2018 · Expert Opinion on Drug Discovery
28. Microvesicles from cerebrospinal fluid of patients with Alzheimer’s disease display reduced concentrations of tau and APP protein
    Philipp Spitzer, Linda‐Marie Mulzer, Timo Jan Oberstein, Luis Enrique Munoz, Piotr Lewczuk, Johannes Kornhuber, Martin Herrmann i, Juan Manuel Maler · 2019 · Scientific Reports
29. Dynamic 3D On-Chip BBB Model Design, Development, and Applications in Neurological Diseases
    Xingchi Chen, Chang Liu, Laureana Muok, Changchun Zeng, Yan Li · 2021 · Cells
30. Neurophysiological signals as predictive translational biomarkers for Alzheimer’s disease treatment: effects of donepezil on neuronal network oscillations in TgF344-AD rats
    Milan Stoiljković, Craig Kelley, Tamás L. Horváth, Mihály Hajós · 2018 · Alzheimer s Research & Therapy
31. Recent Advances in Pharmaceutical Potential of Brown Algal Polysaccharides and their Derivatives
    Jun Li, Chao Cai, Chendong Yang, Jianghua Li, Tiantian Sun, Guangli Yu · 2019 · Current Pharmaceutical Design
32. Projecting the long‐term societal value of a disease‐modifying treatment for Alzheimer's disease in the United States
    María Prados, Ying Liu, Hankyung Jun, Jenny Lam, Soeren Mattke · 2022 · Alzheimer s & Dementia
33. Brain penetrant kinase inhibitors: Learning from kinase neuroscience discovery
    Yuan Shi, Mary M. Mader · 2018 · Bioorganic & Medicinal Chemistry Letters
34. Neuronal levels and sequence of tau modulate the power of brain rhythms
    Melanie M. Das, Sumihiro Maeda, Bozhong Hu, Gui-Qiu Yu, Weikun Guo, Isabel Lopez, Xinxing Yu, Chao Tai, Xin Wang, Lennart Mucke · 2018 · Neurobiology of Disease
35. Phloroglucinol ameliorates cognitive impairments by reducing the amyloid β peptide burden and pro-inflammatory cytokines in the hippocampus of 5XFAD mice
    Eun-Jeong Yang, Usman Mahmood, Hyun-Ju Kim, Moonseok Choi, Yunjung Choi, Jean‐Pyo Lee, Joo‐Youn Cho, Jin Won Hyun, Yong Sik Kim, Moon‐Jeong Chang et al. · 2018 · Free Radical Biology and Medicine
36. The role of TREM2 in Alzheimer's disease; evidence from transgenic mouse models
    Luciné Karanfilian, Maria Grazia Tosto, Karim Malki · 2019 · Neurobiology of Aging
37. SANE: A sequence combined attentive network embedding model for COVID-19 drug repositioning
    Xiaorui Su, Zhu‐Hong You, Lei Wang, Lun Hu, Leon Wong, Boya Ji, Bo-Wei Zhao · 2021 · Applied Soft Computing
38. Guanidine-based β amyloid precursor protein cleavage enzyme 1 (BACE-1) inhibitors for the Alzheimer's disease (AD): A review
    Pinky Gehlot, Sunil Kumar, Vivek K. Vyas, Bhanwar Singh Choudhary, Manish Sharma, Ruchi Malik · 2022 · Bioorganic & Medicinal Chemistry
39. Representation of ethnic groups in dementia trials: systematic review and meta-analysis
    Manav V. Vyas, Pranali K. Raval, Jennifer Ann Watt, David F. Tang‐Wai · 2018 · Journal of the Neurological Sciences
40. A Novel Neuroregenerative Approach Using ETB Receptor Agonist, IRL-1620, to Treat CNS Disorders
    Anil Gulati, Mary G. Hornick, Seema Briyal, Manish S Lavhale · 2018 · Physiological Research
41. The development of an automated machine learning pipeline for the detection of Alzheimer’s Disease
    Nicholas R. Chedid, Judie Tabbal, Aya Kabbara, Sahar Allouch, Mahmoud Hassan · 2022 · Scientific Reports
42. Modulation of Alzheimer's amyloid β peptide oligomerization and toxicity by extracellular Hsp70
    Isabel Rivera, Ricardo F. Capone, David M. Cauvi, Nelson J. Arispe, Antonio De Maio · 2017 · Cell Stress and Chaperones
43. Protective Effects of 6-(Methylsulfinyl)hexyl Isothiocyanate on Aβ1-42-Induced Cognitive Deficit, Oxidative Stress, Inflammation, and Apoptosis in Mice
    Fabiana Morroni, Giulia Sita, Agnese Graziosi, Eleonora Turrini, Carmela Fimognari, Andrea Tarozzi, Patrizia Hrelia · 2018 · International Journal of Molecular Sciences
44. Phenylpropanoids and Alzheimer's disease: A potential therapeutic platform
    Igri Kolaj, S. Imindu Liyanage, Donald Fredric Weaver · 2018 · Neurochemistry International
45. Anti-amyloid Therapy of Alzheimer’s Disease: Current State and Prospects
    Sergey A. Kozin, Evgeny P. Barykin, Vladimir A. Mitkevich, Alexander А. Makarov · 2018 · Biochemistry (Moscow)
46. Combination Therapy for Alzheimer's Disease: Perspectives of the EU/US CTAD Task Force
    Serge G. Gauthier, J. Alam, Howard M. Fillit, Takeshi Iwatsubo, H. Liu-Seifert, Marwan Noel Sabbagh, Stephen Salloway, Cristina Sampaio, John Randall Sims, B. K. Sperling et al. · 2019 · The Journal of Prevention of Alzheimer s Disease
47. Saponins and flavonoids from Bacopa floribunda plant extract exhibit antioxidant and anti-inflammatory effects on amyloid beta 1-42-induced Alzheimer's disease in BALB/c mice
    Mosunmola Busayo Oyeleke, Bamidele Victor Owoyele · 2022 · Journal of Ethnopharmacology
48. New directions for protease inhibitors directed drug discovery
    Yoshio Hamada, Yoshiaki Kiso · 2015 · Biopolymers
49. Recent Advances: Decoding Alzheimer’s Disease With Stem Cells
    Yi Fang, Ting Gao, Baorong Zhang, Jiali Pu · 2018 · Frontiers in Aging Neuroscience
50. A small molecule Nec-1 directly induces amyloid clearance in the brains of aged APP/PS1 mice
    Seung‐Hoon Yang, Jisu Shin, Naewoo Neo Shin, Ji‐Hyun Hwang, Sung-Chul Hong, Keunwan Park, Jae Wook Lee, Sejin Lee, Seungyeop Baek, Kyeonghwan Kim et al. · 2019 · Scientific Reports
51. Protein phosphatase 2A and complement component 4 are linked to the protective effect of APOE ɛ2 for Alzheimer's disease
    Gyungah Jun, Yang You, Congcong Zhu, Gaoyuan Meng, Jaeyoon Chung, Rebecca Panitch, Junming Hu, Weiming Xia, David Alan Bennett, Tatiana Foroud et al. · 2022 · Alzheimer s & Dementia
52. A Signature of Five Long Non-Coding RNAs for Predicting the Prognosis of Alzheimer's Disease Based on Competing Endogenous RNA Networks
    Huaying, Cai, Xing, Jin, Luya, Jin, Linhui, Ni, Di, Sun, Xianjun, Ding · 2021 · Frontiers in Aging Neuroscience
53. Tau Conformation as a Target for Disease-Modifying Therapy: The Role of Truncation
    Petr Novák, Ondrej Cehlár, Rostislav Škrabana, Michal Novák · 2018 · Journal of Alzheimer s Disease
54. Current druggable targets for therapeutic control of Alzheimer's disease
    Girdhari Lal Gupta, Nikita Patil Samant · 2021 · Contemporary Clinical Trials
55. A patent review of butyrylcholinesterase inhibitors and reactivators 2010–2017
    Vincenza Andrisano, Marina Naldi, Angela De Simone, Manuela Bartolini · 2018 · Expert Opinion on Therapeutic Patents
56. The application of multifunctional nanomaterials in Alzheimer’s disease: A potential theranostics strategy
    Yilan Xu, Man-Na Zhao, Dongming Zhou, Tingting Zheng, Heng Zhang · 2021 · Biomedicine & Pharmacotherapy
57. Far infrared light irradiation enhances Aβ clearance via increased exocytotic microglial ATP and ameliorates cognitive deficit in Alzheimer’s disease-like mice
    Qingyong Li, Jun Peng, Yuelian Luo, Jiaxin Zhou, Tailin Li, Lin Sen Cao, Shuling Peng, Zhiyi Zuo, Zhi Wang · 2022 · Journal of Neuroinflammation
58. Clinical trials in dementia with Lewy bodies: the evolving concept of co-pathologies, patient selection and biomarkers
    Lucy L. Gibson, Carla Abdelnour Ruiz, Joyce Ruifen Chong, Clive G. Ballard, Dag Aarsland · 2023 · Current Opinion in Neurology
59. Inhibition of 14-3-3/Tau by Hybrid Small-Molecule Peptides Operating via Two Different Binding Modes
    Sebastian A. Andrei, Femke A. Meijer, João Filipe Neves, Luc Brunsveld, Isabelle Landrieu, Christian Ottmann, L.‐G. Milroy · 2018 · ACS Chemical Neuroscience
60. Insights into Structure-Activity Relationships of 3-Arylhydrazonoindolin-2-One Derivatives for Their Multitarget Activity on β-Amyloid Aggregation and Neurotoxicity
    Rosa Purgatorio, Modesto de Candia, Annalisa De Palma, Francesco De Santis, Leonardo Pisani, Francesco Campagna, Saverio Cellamare, Cosimo Altomare, Marco Catto · 2018 · Molecules
61. Semi-synthetic isoflavones as BACE-1 inhibitors against Alzheimer’s disease
    Giovanni Ribaudo, Paolo Saul Coghi, Enrico Zanforlin, Betty Yuen Kwan Law, Yuki Yu Jun Wu, Yu Kyeong Han, Alena Cong Ling Qiu, Yuan Qing Qu, Giuseppe Zagotto, Vincent Kam Wai Wong · 2019 · Bioorganic Chemistry
62. Acetylcholinesterase inhibitors combined with memantine for moderate to severe Alzheimer's disease: a meta-analysis
    Dominik Glinz, Viktoria Gloy, Andreas Urs Monsch, Reto Werner Kressig, Chandni Patel, Kimberly A McCord, Zanfina Ademi, Yuki Tomonaga, Matthias M. Schwenkglenks, Heiner C. Bucher et al. · 2019 · Swiss Medical Weekly
63. Evaluation of Class IIa Histone Deacetylases Expression and In Vivo Epigenetic Imaging in a Transgenic Mouse Model of Alzheimer’s Disease
    Yi‐An Chen, Cheng-Hsiu Lu, Chien‐Chih Ke, Sain-Jhih Chiu, Chi‐Wei Chang, Bang‐Hung Yang, Juri George Gelovani, Ren-Shyan Liu · 2021 · International Journal of Molecular Sciences
64. The Pathological Effects of Circulating Hydrophobic Bile Acids in Alzheimer’s Disease
    Touraj Ehtezazi, Khalid Rahman, Rhys Davies, Andrew G. Leach · 2023 · Journal of Alzheimer s Disease Reports
65. Enriched Environment Significantly Reduced Senile Plaques in a Transgenic Mice Model of Alzheimer’s Disease, Improving Memory
    Janaina Balthazar, Natália Mendes Schöwe, Gabriela Cabett Cipolli, Hudson Sousa Buck, Tânia Araújo Viel · 2018 · Frontiers in Aging Neuroscience
66. Uncaria rhynchophylla ameliorates amyloid beta deposition and amyloid beta-mediated pathology in 5XFAD mice
    Soo Jung Shin, Yu-on Jeong, Seong Gak Jeon, Sujin Kim, Seong-kyung Lee, Hong Seok Choi, Cheong Su Im, Seong Hee Kim, Soo Hwan Kim, Jae Ho Park et al. · 2018 · Neurochemistry International
67. New piperazine multi-effect drugs prevent neurofibrillary degeneration and amyloid deposition, and preserve memory in animal models of Alzheimer's disease
    Nicolas Sergeant, Valérie Vingtdeux, Sabiha Eddarkaoui, Marion Gay, Caroline Evrard, Nicolas Le Fur, Cyril Laurent, Raphaëlle Caillierez, Hélène Obriot, Paul-Emmanuel Larchanché et al. · 2019 · Neurobiology of Disease
68. Stem cells as a promising therapeutic approach for Alzheimer’s disease: a review
    Ghadha Ibrahim Fouad · 2019 · Bulletin of the National Research Centre/Bulletin of the National Research Center
69. Altered glia-neuron communication in Alzheimer’s Disease affects WNT, p53, and NFkB Signaling determined by snRNA-seq
    Tabea M. Soelter, Timothy C. Howton, Amanda D. Clark, Vishal H. Oza, Brittany N. Lasseigne · 2024 · Cell Communication and Signaling
70. A Network-Based Perspective in Alzheimer's Disease: Current State and an Integrative Framework
    Andrei Dragomir, Aristidis G. Vrahatis, Anastasios Bezerianos · 2018 · IEEE Journal of Biomedical and Health Informatics
71. Alzheimer’s Disease (AD) Therapeutics—2: Beyond Amyloid—Re-Defining AD and Its Causality to Discover Effective Therapeutics
    Mullane, Kevin, Williams, Michael · 2018 · Biochemical Pharmacology
72. AAV-mediated neuronal expression of an scFv antibody selective for Aβ oligomers protects synapses and rescues memory in Alzheimer models
    María Clara Sellés, Juliana T.S. Fortuna, Magalí Cecilia Cercato, Luís E. Santos, Luciana Domett, Andre L.B. Bitencourt, Mariane Favero Carraro, Amanda Santos de Souza, Helena Janíčková, Caroline Vieira Azevedo et al. · 2022 · Molecular Therapy
73. A Conformation Variant of p53 Combined with Machine Learning Identifies Alzheimer Disease in Preclinical and Prodromal Stages
    Giulia Abate, Marika Vezzoli, Letizia Polito, Antonio Guaita, Diego Albani, Moira Marizzoni, Emirena Garrafa, Alessandra Marengoni, Gianluigi Forloni, Giovanni Battista Frisoni et al. · 2020 · Journal of Personalized Medicine
74. Design, synthesis and evaluation of cinnamic acid hybrids as multi-target-directed agents for the treatment of Alzheimer’s disease
    Keren Wang, Jian Shi, Yi Ming Zhou, Ying He, Jing Mi, Jing Liang Yang, Shuang Liu, Xiangcheng Tang, Wenmin Liu, Zhenghuai Tan et al. · 2021 · Bioorganic Chemistry
75. Network-based stage-specific drug repurposing for Alzheimer’s disease
    Kyriaki Savva, Margarita Zachariou, Marilena M. Bourdakou, Nikolas Dietis, George M. Spyrou · 2022 · Computational and Structural Biotechnology Journal
76. Machine learning based multi-modal prediction of future decline toward Alzheimer’s disease: An empirical study
    Batuhan K. Karaman, Elizabeth C. Mormino, Mert Rory Sabuncu, Alzheimer’s Disease Neuroimaging Initiative · 2022 · PLoS ONE
77. The long-lived Octodon degus as a rodent drug discovery model for Alzheimer's and other age-related diseases
    Michael J. Hurley, Robert M. J. Deacon, Katrin Beyer, Elena Ioannou, Agustín M. Ibáñez, Jessica L. Teeling, Patricia Cogram · 2018 · Pharmacology & Therapeutics
78. A vaccine against Alzheimer`s disease: anything left but faith?
    Martin F. Bachmann, Gary T. Jennings, Monique Vogel · 2018 · Expert Opinion on Biological Therapy
79. Dementia treatment versus prevention
    Robert Perneczky · 2019 · Phlebolymphology
80. Alzheimers sykdom – diagnostikk og behandling
    Anne‐Brita Knapskog, Knut Engedal, Geir Selbæk, Anne‐Rita Öksengård · 2021 · Tidsskrift for Den norske legeforening
81. Regulatory-accepted drug development tools are needed to accelerate innovative CNS disease treatments
    Stephen P. Arnerić, Volker D. Kern, Diane T. Stephenson · 2018 · Biochemical Pharmacology
82. The Proactive Patient: Long-Term Care Insurance Discrimination Risks of Alzheimer's Disease Biomarkers
    Jalayne J. Arias, Ana M. Tyler, Benjamin J Oster, Jason H. Karlawish · 2018 · The Journal of Law Medicine & Ethics
83. Multiple BACE1 inhibitors abnormally increase the BACE1 protein level in neurons by prolonging its half‐life
    Lei Liu, Bianca M. Lauro, Ding Li, Matteo Rovere, Michael S. Wolfe, Dennis J. Selkoe · 2019 · Alzheimer s & Dementia
84. Circular RNA aptamers targeting neuroinflammation ameliorate Alzheimer disease phenotypes in mouse models
    Xin Feng, Bowen Jiang, Si-Nan Zhai, Chu‐Xiao Liu, Hao Wu, Bang-Qi Zhu, Meng-Yuan Wei, Jia Wei, Li Chun Yang, Ling‐Ling Chen · 2025 · Nature Biotechnology
85. Small Molecule Natural Products and Alzheimer’s Disease
    Xiaoai Wu, Huawei Cai, Lili Pan, Gang Cui, Feng Qin, Yun‐Chun Li, Zhengxin Cai · 2019 · Current Topics in Medicinal Chemistry
86. Lithium chloride reduced the level of oxidative stress in brains and serums of APP/PS1 double transgenic mice via the regulation of GSK3β/Nrf2/HO-1 pathway
    Jie Xiang, Kun Cao, Yang‐Ting Dong, Yi Xu, Yi Li, Hui Song, Xiaoxiao Zeng, Long‐Yan Ran, Wei Hong, Zhi‐Zhong Guan · 2019 · International Journal of Neuroscience
87. Impact of Four Common Hydrogels on Amyloid-β (Aβ) Aggregation and Cytotoxicity: Implications for 3D Models of Alzheimer’s Disease
    Laura W. Simpson, Gregory Lee Szeto, Hacène Boukari, Theresa A. Good, Jennie Baier Leach · 2020 · ACS Omega
88. Accelerating Alzheimer's disease drug innovations from the research pipeline to patients
    Goldman, Dana P., Fillit, Howard, Neumann, Peter · 2018 · Alzheimer's & Dementia
89. Deep and Frequent Phenotyping study protocol: an observational study in prodromal Alzheimer’s disease
    Ivan G. Koychev, Jennifer Lawson, Tharani Chessell, Clare E. Mackay, Roger N. Gunn, Barbara Jacquelyn Sahakian, James Benedict Rowe, Alan J. Thomas, Lynn Rochester, Dennis Chan et al. · 2019 · BMJ Open
90. A dual inhibitor of the proteasome catalytic subunits LMP2 and Y attenuates disease progression in mouse models of Alzheimer’s disease
    In Jun Yeo, Min Jae Lee, Ahruem Baek, Zachary C. Miller, Deepak Bhattarai, Yu Mi Baek, Hyun Jung Jeong, Yun Kyung Kim, Dong‐Eun Kim, Jin Tae Hong et al. · 2019 · Scientific Reports
91. Development of the clinical candidate PBD-C06, a humanized pGlu3-Aβ-specific antibody against Alzheimer’s disease with reduced complement activation
    Thore Hettmann, Stephen D. Gillies, Martin Kleinschmidt, Anke Piechotta, Koki Makioka, Cynthia Ann Lemere, Stephan Schilling, Jens‐Ulrich Rahfeld, Inge Lues · 2020 · Scientific Reports
92. Advances in Drug Therapy for Alzheimer’s Disease
    Chuan-cong Zhu, Siyu Fu, Yuxin Chen, Ling Li, Ruolin Mao, Jian‐Zhi Wang, Rong Liu, Yi Liu, Xiaochuan Wang · 2020 · Current Medical Science
93. DJ‑1 affects oxidative stress and pyroptosis in hippocampal neurons of Alzheimer's disease mouse model by regulating the Nrf2 pathway
    Lin Cheng, Wei Zhang · 2021 · Experimental and Therapeutic Medicine
94. Cognitive practice effects delay diagnosis of MCI: Implications for clinical trials
    Mark E. Sanderson‐Cimino, Jeremy A. Elman, Xin Ming Tu, Alden L. Gross, Matthew S. Panizzon, Daniel E. Gustavson, Mark William Bondi, Emily C. Edmonds, Graham M.L. Eglit, Joel S. Eppig et al. · 2022 · Alzheimer s & Dementia Translational Research & Clinical Interventions
95. Shared genetic loci between Alzheimer's disease and multiple sclerosis: Crossroads between neurodegeneration and immune system
    Vera Fominykh, Alexey A. Shadrin, Piotr Pawel Jaholkowski, Shahram Bahrami, Lavinia Athanasiu, Douglas P. Wightman, Emil Uffelmann, Daniëlle Posthuma, Geir Selbæk, Anders Martin Dale et al. · 2023 · Neurobiology of Disease
96. Dual Specificity Phosphatase 6 Protects Neural Stem Cells from β-Amyloid-Induced Cytotoxicity through ERK1/2 Inactivation
    Wang Liao, Yuqiu Zheng, Wenli Fang, Shaowei Liao, Ying Xiong, Yi Li, Songhua Xiao, Xingcai Zhang, Jun Liu · 2018 · Biomolecules
97. Screening of Some Sulfonamide and Sulfonylurea Derivatives as Anti-Alzheimer’s Agents Targeting BACE1 and PPARγ
    Ning Li, Yan Wang, Wensheng Li, Haiyan Li, Liu Yang, Jun Wang, Hazem A. Mahdy, Ahmed B. M. Mehany, Dareen A. Jaiash, Eman Y. Santali et al. · 2020 · Journal of Chemistry
98. Navitoclax safety, tolerability, and effect on biomarkers of senescence and neurodegeneration in aged nonhuman primates
    Edward F. Greenberg, Martin J. Voorbach, Alexandra G. Smith, David R. Reuter, Yuchuan Zhuang, Ji-Quan Wang, Dustin Wooten, Elizabeth Asque, Min Hu, Carolin Hoft et al. · 2024 · Heliyon
99. Statistical advances in clinical trials and clinical research
    Guogen Shan, Sarah Jane Banks, Justin B. Miller, Aaron R. Ritter, Charles B. Bernick, Joseph M. Lombardo, Jeffrey L. Cummings · 2018 · Alzheimer s & Dementia Translational Research & Clinical Interventions
100. Neurotropin reduces memory impairment and neuroinflammation via BDNF/NF-κB in a transgenic mouse model of Alzheimer's disease.
     Wenli Fang, Wang Liao, Yuqiu Zheng, Xiaoyun Huang, Xueling Weng, Shengnuo Fan, Xiaoyu Chen, Xing‐Mei Zhang, Jianjun Chen, Songhua Xiao et al. · 2019 · Europe PMC (PubMed Central)